Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase fak'

Search results for: 'research area tyrosine kinase fak'

Items 81-90 of 242

Page
per page
  1. AG-490
    A4139 AG-490
     3 Citation
    Target: EGFR|JAK
    Summary: JAK2/EGFR inhibitor
      insoluble in H2O; ≥14.7 mg/mL
  2. ARRY-380
    A8366 ARRY-380
    Target: HER2
    Summary: Tyrosine kinase HER2 and p95-HER2 inhibitor
      ≥28.5 mg/mL
  3. TAE226 (NVP-TAE226)
    A8557 TAE226 (NVP-TAE226)
     1 Citation
    Target: FAK
    Summary: FAK inhibitor,potent and ATP-competitive
      ≥23.45 mg/mL
  4. Vatalanib (PTK787) 2HCl
    A1778 Vatalanib (PTK787) 2HCl
    Target: VEGFR
    Summary: Tyrosine kinase receptor inhibitor
      ≥21 mg/mL
  5. PHA-793887
    A5459 PHA-793887
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Pan-Cdk inhibitor
      insoluble in H2O; ≥18.05 mg/mL
  6. Palbociclib (PD0332991) Isethionate
    A8335 Palbociclib (PD0332991) Isethionate
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor,highly selective
      ≥28.7 mg/mL
  7. PHA-848125
    A8501 PHA-848125
    Target: Cyclin-Dependent Kinases
    Summary: CDK inhibitor,potent and ATP-competitive
      ≥23.05 mg/mL
  8. BMS265246
    A8385 BMS265246
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/2 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥17.25 mg/mL
  9. LEE011
    A8641 LEE011
    Target: Cyclin-Dependent Kinases
    Summary: CDK4/6 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.88 mg/mL
  10. 5-Iodotubercidin
    A3125 5-Iodotubercidin
    Target: Adenosine Kinases
    Summary: Adenosine kinase inhibitor,potent
      ≥83 mg/mL

Items 81-90 of 242

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Apoptosis 3item
  2. Chromatin/Epigenetics 24item
  3. Metabolism 1 item
  4. MAPK Signaling 20item
  5. Tyrosine Kinase 86item
  6. DNA Damage/DNA Repair 6item
  7. PI3K/Akt/mTOR Signaling 34item
  8. Cell Cycle/Checkpoint 54item
  9. Ubiquitination/ Proteasome 3item
  10. JAK/STAT Signaling 20item
  11. TGF-β / Smad Signaling 26item
  12. Angiogenesis 1 item
  13. GPCR/G protein 2item
  14. Stem Cell 6item
  15. Membrane Transporter/Ion Channel 3item
  16. Others 14item
  17. Immunology/Inflammation 1 item
Reversibility
  1. Reversible 21item
  2. Irreversible 5item
Target
  1. Cyclin-Dependent Kinases 21item
  2. Akt 1 item
  3. PI3K 12item
  4. Raf 7item
  5. Aurora Kinases 13item
  6. CSF-1R 2item
  7. mTOR 6item
  8. FLT3 8item
  9. GSK-3 7item
  10. PLK 4item
  11. Chk 5item
  12. Eph Receptors 3item
  13. VEGFR 19item
  14. PDGFR 14item
  15. c-Kit 6item
  16. RET 3item
  17. IRAK 2item
  18. Bromodomain-containing proteins(BRDs) 1 item
  19. p38 6item
  20. PKB 1 item
  21. JNK 2item
  22. SGK 2item
  23. Bcr-Abl 10item
  24. MEK 4item
  25. FGFR 6item
  26. Pim 4item
  27. Ribosomal s6 kinases (RSK) 1 item
  28. MET 5item
  29. Src 8item
  30. Trk Receptors 2item
  31. STAT 1 item
  32. EGFR 10item
  33. ROCK 6item
  34. BTK 1 item
  35. PAK 3item
  36. FAK 5item
  37. BMP and Other Activin Receptors 2item
  38. JAK 9item
  39. Syk 5item
  40. DNA-PK 3item
  41. AMPK 2item
  42. PDHK 1 item
  43. ErbB 2item
  44. S6 kinases 1 item
  45. Adenosine Kinases 2item
  46. ERK 2item
  47. c-MET 5item
  48. PKC 5item
  49. Ubiquitin-specific proteases 1 item
  50. Ca2 /calmodulin-dependent protein kinases (CaMKs) 6item
  51. Lyn 1 item
  52. HER2 2item
  53. Pyk2 3item
  54. LRRK2 3item
  55. Insulin and Insulin-like Receptors 2item
  56. ALK 3item
  57. ROS1 1 item
  58. Sphingosine kinases (SphKs) 1 item
  59. PKG 1 item
  60. PKA 1 item
  61. Myosin light chain kinases (MLCKs) 2item
  62. CaM-KK 1 item
  63. MELK 1 item
  64. Insulin-like growth factors (IGFs) 1 item
  65. Clk 1 item
  66. NUAK1 1 item
  67. NUAK2 1 item
  68. MK2 2item
  69. Fatty-acid-binding proteins (FABPs) 1 item
  70. Tie-2 2item
  71. RSK 1 item
  72. ATM/ATR 3item
  73. CK1 1 item
  74. Farnesyl Diphosphate Synthases 1 item
  75. CK2 3item
  76. HIPK2 1 item
  77. HIPK3 1 item
  78. P2X Receptors 1 item
  79. c-Fyn 1 item
  80. TAK1 1 item
  81. P110 1 item
  82. Hck 1 item
  83. Insulin Receptors 1 item
  84. IRG-1R 1 item
  85. eEF-2 1 item
  86. Cdc7 1 item
  87. ZAP-70 1 item
  88. c-RET 1 item
  89. p70 rsk 1 item
  90. TAM kinase 1 item
  91. AXL 1 item
  92. c-Fms tyrosine kinase 1 item
  93. STK 1 item
  94. MSK 1 item
  95. Lyn kinase 1 item
  96. ITK 1 item
  97. NUAK 1 item
  98. DCLK2 1 item
  99. Lck 1 item
  100. PKD 1 item
  101. tropomyosin receptor kinase 1 item
  102. SK 1 item
  103. ATM 1 item
  104. PIKfyve 1 item
  105. Insulin Receptor 1 item
Reported Experiments
  1. Animal Experiments 210item
  2. Cell Experiments 128item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 16item
  3. Adrenocortical Carcinoma 2item
  4. Advanced Renal Cell Carcinoma 1 item
  5. Bladder Cancer 4item
  6. Bladder Carcinoma 1 item
  7. B-lymphoid Malignancies 1 item
  8. Breast Cancer 43item
  9. Cancer 155item
  10. Cervical Cancer 4item
  11. Cholangiocarcinoma 2item
  12. Chronic Lymphocytic Leukemia 2item
  13. Clear Cell Renal Cell Carcinoma 1 item
  14. Colon Cancer 20item
  15. Colon Carcinoma 2item
  16. Colorectal Cancer 19item
  17. Diabetes 1 item
  18. Glioblastoma 17item
  19. Glioma 7item
  20. Hepatocellular Carcinoma 4item
  21. HIV Infections 1 item
  22. Immunological Diseases 1 item
  23. Inflammatory Bowel Disease 1 item
  24. Inflammatory Diseases 4item
  25. Leukemia 7item
  26. Liver Cancer 3item
  27. Lung Cancer 15item
  28. Lung Carcinoma 3item
  29. Lymphoma 9item
  30. Mantle Cell Lymphoma 1 item
  31. Melanoma 11item
  32. Multiple Myeloma 6item
  33. Myelofibrosis 1 item
  34. Myeloma 1 item
  35. Neuroblastoma 2item
  36. Non-small Cell Lung Cancer 5item
  37. Non-small Cell Lung Carcinoma 1 item
  38. Ovarian Cancer 15item
  39. Pancreatic Cancer 22item
  40. Prostate Cancer 17item
  41. Psoriasis 1 item
  42. Pulmonary Arterial Hypertension 1 item
  43. Renal Cancer 3item
  44. Renal Cell Carcinoma 5item
  45. Rheumatoid Arthritis 5item
  46. Thyroid Cancer 5item
  47. Type 2 Diabetes 3item